Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Molecular mechanism of resveratrol combined with irinotecan in treatment of colorectal cancerLi, Fang ; Yan, Rui-Yang ; Li, Kai-Yang ; Wang, Jue ; Wang, Li ; Shen, Hui ; Han, Cai-Li ; Liu, MinZhongguo zhongyao zazhi, 2023-04, Vol.48 (8), p.2212-2221 [Periódico revisado por pares]ChinaTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Analysis of the Efficacy of Irinotecan in the Second-line Treatment of Refractory and Relapsed Small Cell Lung CancerXing, He ; Zhang, Jie ; Ge, Fengjuan ; Yu, Xinhang ; Bian, Huimin ; Zhang, Fuliang ; Fang, JianZhongguo fei ai za zhi, 2021-03, Vol.24 (3), p.167-172 [Periódico revisado por pares]China: Chinese Anti-Cancer Association Chinese Antituberculosis AssociationTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Clinical Observation of mXELIRI and mFOLFIRI Combined with Cetuximab in First-line Treatment of Metastatic Left-side Colon CancerCHENG Jianping ; ZHAO Xiaolin ; LI Zhen ; YANG Mengyuan ; CAO Shichang ; YU JiufeiZhongliu fangzhi yanjiu, 2020-07, Vol.47 (7), p.542-546 [Periódico revisado por pares]Magazine House of Cancer Research on Prevention and TreatmentTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Clinical Observation of mXELIRI and mFOLFIRI Combined with Cetuximab in Firstline Treatment of Metastatic Left-side Colon CancerCheng, Jianping ; Zhao, Xiaolin ; Li, Zhen ; Yang, Mengyuan ; Cao, Shichang ; Yu, JiufeiZhongliu fangzhi yanjiu, 2020-07, Vol.47 (7), p.542 [Periódico revisado por pares]Tianjin: China Anti-Cancer AssociationTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild‐type metastatic colorectal cancer patients: promising findings from a prospective, open‐label, randomized, phase III trialShi, Yuankai ; Li, Jin ; Xu, Jianming ; Sun, Yan ; Wang, Liwei ; Cheng, Ying ; Liu, Wei ; Sun, Guoping ; Chen, Yigui ; Bai, Li ; Zhang, Yiping ; He, Xiaohui ; Luo, Yi ; Wang, Zhehai ; Liu, Yunpeng ; Yao, Qiang ; Li, Yuhong ; Qin, Shukui ; Hu, Xiaohua ; Bi, Feng ; Zheng, Rongsheng ; Ouyang, XuenongCancer communications (London, England), 2019-05, Vol.39 (1), p.1-13 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
The efficacy and safety of modified FOLFIRINOX as first‐line chemotherapy for Chinese patients with metastatic pancreatic cancerWang, Zhi‐Qiang ; Zhang, Fei ; Deng, Ting ; Zhang, Le ; Feng, Fen ; Wang, Feng‐Hua ; Wang, Wei ; Wang, De‐Shen ; Luo, Hui‐Yan ; Xu, Rui‐Hua ; Ba, Yi ; Li, Yu‐HongCancer communications (London, England), 2019-05, Vol.39 (1), p.1-8 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Irinotecan plus S‐1 versus S‐1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open‐labeled phase 3 trialHuang, Jing ; Xu, Binghe ; Liu, Ying ; Huang, Junxing ; Lu, Ping ; Ba, Yi ; Wu, Lin ; Bai, Yuxian ; Zhang, Shu ; Feng, Jifeng ; Cheng, Ying ; Li, Jie ; Wen, Lu ; Yuan, Xianglin ; Ma, Changwu ; Hu, Chunhong ; Fan, Qingxia ; Wang, XiCancer communications (London, England), 2019-04, Vol.39 (1), p.1-10 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Effect of basic fibroblast growth factor antibody combined with irinotecan on proliferation and apoptosis of small cell lung cancer H223 cells in vitroLiao, Xiang-Hui ; Xu, Meng ; Xiang, Jun-JianNan fang yi ke da xue xue bao = Journal of Southern Medical University, 2017-11, Vol.37 (11), p.1535-1539ChinaTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Clinical Observation of Raltitrexed-based Regimen for Advanced Primary Liver CarcinomaKe, Wen ; Hua, Haiqing ; Qin, Shukui ; Qu, Wenshu ; Wang, FengZhongliu fangzhi yanjiu, 2017-04, Vol.44 (4), p.281 [Periódico revisado por pares]Tianjin: China Anti-Cancer AssociationTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
A retrospective study of the efficacy and toxicity of irinotecan in combination with nedaplatin versus irinotecan in combination with cisplatin as salvage treatment in refractory or relapsed small cell lung cancerYu, Shufei ; Wang, Yan ; Hu, Xingsheng ; Wang, Hongyu ; Hao, Xuezhi ; Xu, Jianping ; Li, Junling ; Zhang, Xiangru ; Shi, YuankaiZhongguo fei ai za zhi, 2013-09, Vol.16 (9), p.470-475 [Periódico revisado por pares]China: Chinese Anti-Cancer Association Chinese Antituberculosis AssociationTexto completo disponível |